UNSPSC 51392701: Saterinone

This classification denotes a phosphodiesterase inhibitor with the molecular formula C27H30N4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W4P85FO7GS, chemically known as (+-)-1,2-dihydro-5-(p-(2-hydroxy-3-(4-(o-methoxyphenyl)-1-piperazinyl)propoxy)phenyl)-6-methyl-2-oxonicotinonitrile but generally known as saterinone, which bears US NIH Compound Identifier 65874. European Medicines Agency schedules Saterinone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10457MIG.

UNSPSC 51392701 Saterinone is a Commodity code that in practice covers pharmaceutical products and medical supplies for overdose response and substance-abuse harm reduction, specifically naloxone (an opioid antagonist) and drug deactivation systems procured by state and local public health and emergency-services agencies. State and local governments buy these products to support community health initiatives, overdose prevention programs, and emergency medical response capabilities. The solicitations show county health departments and public safety entities as the primary issuing bodies, acquiring naloxone and associated drug-disposal or deactivation systems in bulk quantities for distribution through community health facilities and emergency responders.

Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS) in June 2026 seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the notice required electronic bid submission, included E-Verify and drug-free workplace certification requirements, and specified a two-year initial contract term with a one-year renewal option. The source shows limited recent activity beyond this single opportunity and does not support characterization of geographic or issuing-body concentration across multiple states or jurisdictions.